CLINICAL EFFICACY AND SAFETY OF INSULIN ASPART COMPARED WITH REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS RECEIVING PRANDIAL INSULIN REGIMEN - A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Wojciechowski, P. [1 ]
Niemczyk-Szechowska, P. [1 ]
Olewinska, E. [1 ]
Jaros, P. [1 ]
Jurkiewicz, B. [2 ]
Skarzynska-Duk, J. [2 ]
Mlalecki, M. T. [3 ]
Rys, P. [1 ]
机构：
[1] HTA Consulting, Krakow, Poland
[2] Novo Nordisk Pharma, Warsaw, Poland
[3] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1390
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB4
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [1] Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Wojciechowski, Piotr
    Niemczyk-Szechowska, Patrycja
    Olewinska, Elzbieta
    Jaros, Patrycja
    Mierzejewska, Barbara
    Skarzynska-Duk, Joanna
    Malecki, Maciej T.
    Rys, Przemyslaw
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (03): : 141 - 151
  • [2] Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis (vol 125, pg 141, 2015)
    Wojciechowski, P.
    Niemczyk-Szechowska, P.
    Olewinska, E.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (04): : 308 - 308
  • [3] Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
    Edina, Brenda C.
    Tandaju, Jeremy R.
    Wiyono, Lowilius
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [4] Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review
    Rys, P.
    Pankiewicz, O.
    Lach, K.
    Kwaskowski, A.
    Skrzekowska-Baran, I.
    Malecki, M. T.
    DIABETES & METABOLISM, 2011, 37 (03) : 190 - 200
  • [5] Clinical efficacy and safety of insulin glargine as compared to other insulin preparations in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
    Wojciechowski, P.
    Rys, P.
    Rogoz-Sitek, A.
    Niesyczynski, G.
    Syta, A.
    Lis, J.
    Malecki, M. T.
    DIABETOLOGIA, 2013, 56 : S419 - S419
  • [6] Safety and efficacy of insulin aspart and soluble human insulin in Type 2 diabetes mellitus
    Cucinotta, D.
    Caputo, S.
    Mannucci, E.
    Nicolucci, A.
    Pellegrini, F.
    Perriello, G.
    Sbraccia, P.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (04) : 357 - 366
  • [7] Insulin aspart efficacy and safety compared to human soluble insulin and human premix insulin (30/70) in patients with type 2 diabetes mellitus
    Bretzel, RG
    Medding, J
    Hirschberger, S
    Linn, T
    DIABETOLOGIA, 2001, 44 : A209 - A209
  • [8] Efficacy and Safety of Insulin Aspart 30 and Insulin Degludec/Aspart vs. Basal Insulin in Patients with Type 2 Diabetes: A Meta-analysis
    Mishriky, Basem M.
    Tanenberg, Robert J.
    Cummings, Doyle M.
    DIABETES, 2017, 66 : A252 - A252
  • [9] A comparison of efficacy and safety of insulin aspart and human insulin in treatment of type 1 diabetes mellitus. The results of a systematic review
    Skrzekowska-Baran, I.
    Pankiewicz, O.
    Rys, P.
    Malecki, M. T.
    DIABETOLOGIA, 2009, 52 : S387 - S388
  • [10] A Comparison of Efficacy and Safety of Insulin Aspart and Human Insulin in Treatment of Type 1 Diabetes Mellitus. The Results of a Systematic Review
    Rys, Przemyslaw
    Pankiewicz, Oskar
    Skrzekowska-Baran, Iwona
    Malecki, Maciej T.
    DIABETES, 2009, 58 : A119 - A119
12345